Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
10/18/1995 | EP0677061A1 Polypeptide and anti-hiv agent prepared therefrom |
10/18/1995 | EP0677050A1 Novel pyridone carboxylic acid derivatives |
10/18/1995 | EP0677039A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase |
10/18/1995 | EP0676966A1 Antibodies directed against binding-associated epitopes |
10/18/1995 | EP0676958A1 Method for inhibiting intracellular viral replication |
10/18/1995 | EP0676954A1 Human immunodeficiency virus decoy |
10/18/1995 | EP0596935B1 Antiviral pharmaceutical compositions for vaginal administration |
10/18/1995 | EP0576478B1 Herpes simplex vaccine comprising hsv glycoprotein gd and 3 deacylated monophosphoryl lipid a |
10/18/1995 | EP0495116B1 Anti-human immunodeficiency virus agent |
10/18/1995 | CN1110479A Stereoselective synthesis of nucleoside analogues using bicyclic intermediate |
10/18/1995 | CN1110477A Optically pure salts of pyridinylmethyl sulfinyl-1H-benzimidazole compounds |
10/18/1995 | CN1110323A Novel polypeptides and DNAS encoding them |
10/18/1995 | CN1110280A Targeted forms of methyltrithio antitumor agents |
10/18/1995 | CN1110150A Jiawei double coptis medicament and preparing method thereof |
10/17/1995 | US5459255 For incorporation into oligonucleotides, cleaving RNA site specifically |
10/17/1995 | US5459238 Stimulate cytototoxic T lymphocyte immunity by interacting with human leucocyte antigen; possible AIDS vaccine |
10/17/1995 | US5459235 Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils |
10/17/1995 | US5459159 Anticarcinogenic/antitumor agents; allowing accumulation in abnormal cells, irradiation with light of specified wavelength |
10/17/1995 | US5459141 Compounds 31668P and 31668U, a process for their production and their use |
10/17/1995 | US5459127 Cationic lipids for intracellular delivery of biologically active molecules |
10/17/1995 | US5459060 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) |
10/17/1995 | CA1337333C Legionellosis vaccines and methods for their production |
10/17/1995 | CA1337331C Intranasal vaccination of horses with inactivated micro-organisms or antigenic material |
10/17/1995 | CA1337330C Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components |
10/17/1995 | CA1337328C Odorless aromatic dialdehyde disinfecting and sterilizing composition |
10/15/1995 | CA2163890A1 Dc-89 derivative |
10/12/1995 | WO1995027055A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY |
10/12/1995 | WO1995027053A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING CHYMASE INHIBITING ACTIVITY |
10/12/1995 | WO1995027052A1 Human interleukin variants generated by alternative splicing |
10/12/1995 | WO1995027046A2 Enzymatic antimicrobial compositions containing haloperoxidases |
10/12/1995 | WO1995027044A1 ALPHAVIRUS cDNA VECTORS |
10/12/1995 | WO1995027043A1 Antibacterial therapy with genotypically modified bacteriophage |
10/12/1995 | WO1995026972A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics |
10/12/1995 | WO1995026962A1 Thiazolylpyrazolinones and their use for protecting technical materials |
10/12/1995 | WO1995026960A1 Physiologically active substance ei-1507 |
10/12/1995 | WO1995026751A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR |
10/12/1995 | WO1995026743A1 Nadh oxidase as a target in diagnosis and therapy |
10/12/1995 | WO1995026718A1 Compositions and methods for delivery of genetic material |
10/12/1995 | WO1995024923A3 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
10/12/1995 | CA2187200A1 Nadh oxidase as a target in diagnosis and therapy |
10/12/1995 | CA2186962A1 Antibacterial therapy with genotypically modified bacteriophage |
10/12/1995 | CA2186913A1 Compositions and methods for delivery of genetic material |
10/12/1995 | CA2186908A1 .alpha.-1-antichymotrypsin analogues having elastase inhibitory activity |
10/12/1995 | CA2186854A1 Human interleukin variants generated by alternative splicing |
10/12/1995 | CA2186635A1 .alpha.-1-antichymotrypsin analogues having chymase inhibiting activity |
10/12/1995 | CA2186250A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics |
10/12/1995 | CA2184261A1 Alphavirus cdna vectors |
10/12/1995 | CA2182966A1 Enzymatic antimicrobial compositions |
10/11/1995 | EP0676467A2 European vaccine strains of the porcine reproductive respiratory syndrome virus (PRRSV) |
10/11/1995 | EP0676409A1 Erythromycin derivatives, their process for preparation and their application as medicaments |
10/11/1995 | EP0676198A1 Fungicidal compositions containing a combination of bifonazole and fluocinonide |
10/11/1995 | EP0675961A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis) |
10/11/1995 | EP0675957A1 Vaccines against varicella-zoster virus (vzv) |
10/11/1995 | EP0675955A1 Molecular flashlight |
10/11/1995 | EP0675904A1 Human neutralizing monoclonal antibodies to human immunodeficiency virus |
10/11/1995 | EP0675900A1 Antibiotics ge 37468 a, b and c |
10/11/1995 | EP0675730A1 Therapeutic combination containing interferon |
10/11/1995 | EP0675719A1 Novel combination of benzoquinazoline antifolates and protecting agents |
10/11/1995 | EP0575425B1 USE OF OXAZOLO- 2,3-a]ISOINDOLE AND IMIDAZO 2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO 2,3-a]ISOINDOLE DERIVATIVES |
10/11/1995 | CN1109908A Productive process and use of human anti-tumour alpha type interferon alpha 1/114 Ala, alpha 1/158 Val and mutant thereof |
10/11/1995 | CN1109890A 9a-N-(N'-carbamoyl) and 9a-N-(N'-thiocaramoyl) derivatives of 9-deoxo-9a-aza-9a-homoerythromycin A |
10/11/1995 | CN1109763A Vaccinal efficacy augmentor and efficacy-augmenting foods |
10/11/1995 | CN1029971C Process for preparating antiviral tetrahydroimidazo (1,4) benzodiazepines |
10/11/1995 | CN1029966C Crystalline beta-lactan hydrate |
10/11/1995 | CN1029965C Process and intermediates for beta-lactams having aminothiazole (iminoxyacetic acid) acetic acid sidechains |
10/10/1995 | US5457189 Antisense oligonucleotide inhibition of papillomavirus |
10/10/1995 | US5457129 Inhibition of nitric oxide production by retinoic acid |
10/10/1995 | US5457119 A89271 factors and processes for their production |
10/10/1995 | US5457108 Viricides for treating retroviruses |
10/10/1995 | US5457104 Quinolone- and naphthyridonecarboxylic acid derivatives |
10/10/1995 | US5457096 Antibiotic |
10/10/1995 | US5457091 N1-substituted 1H-1,2,3-triazolo[4,5,-D]pyrimidines, a process for their preparation and their use as antiviral agents |
10/10/1995 | US5457090 A serine proteolytic enzyme inhibitor |
10/10/1995 | US5457038 Natural killer stimulatory factor |
10/10/1995 | US5456924 Method of treatment of HIV-seropositive individuals with dietary whey proteins |
10/10/1995 | CA1337279C Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
10/10/1995 | CA1337267C Canine coronavirus vaccine |
10/05/1995 | WO1995026361A1 Vpr AND Vpx PROTEINS OF HIV |
10/05/1995 | WO1995026352A1 IMIDAZO[1,2-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
10/05/1995 | WO1995026351A1 1,2,4-TRIAZOLO[4,3-a]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
10/05/1995 | WO1995026350A1 Imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one derivatives and pharmaceutical compositions containing same |
10/05/1995 | WO1995026349A1 INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
10/05/1995 | WO1995026202A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
10/05/1995 | WO1995026197A1 Adhesion inhibiting composition |
10/05/1995 | WO1995026196A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON |
10/05/1995 | WO1995026191A1 Injectable solutions of dirithromycin |
10/05/1995 | WO1995026134A1 Composition for inactivating irritants in fluids |
10/05/1995 | DE4411235A1 Thiazolylpyrazolinone Thiazolylpyrazolinone |
10/05/1995 | DE4411025A1 New lipopeptide A1437 derivs. with modified acyl gp. |
10/05/1995 | CA2186856A1 Chimeric infectious bursal disease virus cdna clones, expression products and vaccines based thereon |
10/05/1995 | CA2186398A1 Vpr and vpx proteins of hiv |
10/05/1995 | CA2186390A1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
10/05/1995 | CA2186377A1 Adhesion inhibiting composition |
10/04/1995 | EP0675199A2 A DNA which codes for the variable region of the anti-human influenza A type virus antibody recognizing the H,N, and H2N2 subtypes of haemagglutinin |
10/04/1995 | EP0675122A2 Mono or bicyclic DNA gyrase inhibitors |
10/04/1995 | EP0674905A2 Bacterin for the treatment of necrophorum diseases and a method for the production thereof |
10/04/1995 | EP0674707A1 Compounds and methods for the treatment of leukemias |
10/04/1995 | EP0674657A1 Gp41 mutants and their use as hiv therapeutics |
10/04/1995 | EP0674646A1 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
10/04/1995 | EP0674643A1 Coumarin derivatives as retroviral inhibitors |